Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

Head Of FDA's Food Division Quits Over Job Cuts

Jim Jones, head of the Food & Drug Administration's food division, has reportedly resigned citing widespread layoffs that he believes will hinder regulatory progress.

International Business Times

Hims & Hers: From Viral Ad to Volatile Stock

Hims & Hers leverages its viral Super Bowl advertisement and strategic weight loss market entry to achieve stock gains and brand recognition in telehealth.

MarketBeat

Novo Nordisk Shares Near New 52-Week Low: Analysts See Big Upside

Novo Nordisk shares are closing in on a new 52-week low. Is the stock gearing up for a recovery with sentiment currently low?

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA Recent Hires Fired In Federal Workforce Reduction

Recent workforce reductions at the FDA raise concerns about its ability to ensure public health and safety.

Top News

Trump administration cuts reach FDA employees in food safety, medical devices and tobacco products

The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration this weekend

The Independent UK

Quaker Oats’ recall on product elevated to highest FDA level due to risk of ‘death’

The two-pound boxes of pancake mixe were recalled last month because they may have contained undeclared milk

The Independent UK

We're entering the medical era of wearables

Smartwatches do well selling to consumers, but future devices will focus on medical-grade accuracy to court B2B healthcare sales.

Android Central

Read news from The Economist, FT, and more,
with one subscription

Why Most Pharma Startups Fail—And How Barbara Navarro Strategic Consulting is Turning Struggles into Success

The pharmaceutical and biotech industries are brimming with potential. From revolutionary cancer treatments to cutting-edge gene-editing breakthroughs, start-ups in this space have the power to transform medicine and save lives.

inkl

FDA increases risk level of granola bar recall due to ‘adverse health’ effects

The recall was first issued in December because the granola bars ‘may contain a piece of metal’

The Independent UK

Red dye 3 has been banned in America, what comes next?

Robert F. Kennedy Jr. campaigned on a focus on artificial dyes and other chemicals in food

The Independent UK

Gen Z’s expensive drug habit: Younger patients want brand-name meds that are 79% more expensive

Most Americans would prefer brand-name drugs—but end up buying generic versions because of the cost, new consumer research suggests.

Fortune

Igloo Recalls A Million Coolers Over Fingertip Amputations

The Consumer Product Safety Commission alerted consumers about the recall on Thursday.

International Business Times

Parents can soon use QR codes to reveal heavy metal content in baby food

Parents across the U.S. should soon be able to determine how much lead, arsenic, cadmium and mercury are in the food they feed their babies, thanks to a California law, the first of its kind, that took effect this year.

The Conversation

I Left Florida To Try Lab-Grown Meat

When Florida Gov. Ron DeSantis banned cultivated meat, Reason's Zach Weissmueller visited California labs to try cultivated chicken and salmon and explore the future of this industry.

Reason

Get all your
news in one place.

100’s of premium titles.
One news app.

MarketBeat

Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are Crucial

Eli Lilly is still seeing rapid sales growth for its diabetes and weight loss drugs. However, one drug waiting in the wings hopes to be its next blockbuster.

Salon

Massive pastry recall hits Dunkin'

Affected items may include cinnamon sticks, filled and flavored donuts, French crullers and fritters

Barchart

Wall Street Predicts This Dividend Stock to Soar 31%: Should You Buy The Dip Now?

Amgen stock is an attractive buy on the dip for passive income-focused investors.

MarketBeat

GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends

GLP-1 weight loss drugs are in short supply enabling lab to make compounded GLP-1 treatments sold for 80% less than the name-brand drugs.

Get all your
news in one place.

100’s of premium titles.
One news app.

Salon

House cats with bird flu could pose risk

Pet owners probably shouldn't be afraid their cats will give them bird flu but taking precautions is good for pets

Latin Times

Musk Seemingly Calls for Term Limits as Federal Judge Orders HHS, CDC and FDA to Restore Deleted Webpages: 'Truly Absurd'

Elon Musk demands the removal of a federal judge after a ruling forcing HHS, CDC, and FDA to restore deleted webpages, calling it "truly absurd."

Top News

Federal Judge Orders Restoration Of Health Webpages

Federal judge issues restraining order to restore health-related webpages removed due to executive order, impacting patient care and research.

The Independent UK

Judge tells agencies to restore webpages and data removed after Trump's executive order

A federal judge has told government agencies to restore public access to health-related webpages and datasets they removed to comply with an executive order by President Donald Trump

Barchart

2 ‘Strong Buy’ Growth Stocks Poised for 141% to 193% Gains, According to Wall Street

The recent advancements in their pipelines imply high growth potential in the coming years.

Fortune

Ozempic, Wegovy maker claps back at Hims & Hers Super Bowl ad: ‘Check before you inject’

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and Drug Administration.

LiveScience

Hims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugs

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.

1 … 46 47 48 49

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.